Key result
Direct fetal intramuscular digoxin resolves refractory SVT within ~24 hours, though hydrops fetalis proved fatal.
Why the study?
Data are limited regarding optimal treatment, route of treatment, and medication dosages for refractory fetal tachycardia.
Does fetal intramuscular injection of digoxin resolve refractory supraventricular tachycardia in a fetus with hydrops fetalis?
Case Report (n=1)
No
Does fetal intramuscular injection of digoxin resolve refractory supraventricular tachycardia in a fetus with hydrops fetalis?
Direct fetal intramuscular injection of digoxin may be an effective therapeutic option for refractory fetal SVT, potentially avoiding maternal toxicity associated with high-dose transplacental medications.
Answers are grounded in this paper and cite their sources.
May convert refractory fetal SVT; hypothesis-generating for survival benefit in hydropic cases and should not yet change practice.
Introduction. Few reports have shown promising treatments for refractory fetal tachycardia. Data are limited regarding optimal treatment, route of treatment, and medication dosages. Over 90% of cases of fetal tachycardia can be attributed to supraventricular tachycardia (SVT). The first-line treatment of fetal SVT is transplacental digoxin. Case Presentation. We present the management of a patient with fetal tachyarrhythmia diagnosed at 24 weeks and offer a unique approach for treatment. Fetal intramuscular injection of 72.3 mcg of digoxin allowed for resolution of SVT and sustained normal sinus rhythm. Further assessment in the third trimester showed persistent hydrops in the setting of mirror (Ballantyne’s) syndrome resulting in delivery. Discussion/Conclusion. Our observations suggest that a one-time injection of digoxin allows for complete resolution of SVT. Utilizing an invasive approach for management of SVT that is resistant to traditional treatment modalities appears to both be therapeutic and decrease maternal adverse effects associated with more toxic effects of other transplacental medications.
No takes yet. Share an insight, caveat, or question.
Munoz et al. (2022) conducted a case report in Refractory fetal supraventricular tachycardia complicated by nonimmune hydrops fetalis (n=1). Fetal intramuscular digoxin injection was evaluated on Resolution of fetal supraventricular tachycardia and restoration of normal sinus rhythm. Fetal intramuscular injection of of digoxin resolved refractory supraventricular tachycardia within 24 hours, though persistent hydrops and mirror syndrome led to neonatal demise.
Synapse has enriched 10 related papers. Consider them for comparative context: